[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-369852-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-369852-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","epithelial-competition-determines-gene-therapy-potential-to-suppress-fanconi-anemia-oral-cancer-risk-research-article","Epithelial competition determines gene therapy potential to suppress Fanconi Anemia oral cancer risk - Research article","","Fanconi Anemia (FA) is an inherited DNA damage repair disorder with frequent malformations and markedly elevated risks of bone marrow failure, leukemia, and mucosal head and neck squamous cell carcinomas (HNSCC). While hematopoietic stem cell gene therapy can reduce marrow failure and leukemia, mucosal gene therapy for HNSCC prevention is untested. Using an agent-based oral epithelium model, gene correction delivery to FA cells enables analysis of competitive dynamics and key delivery parameters, including conditions for lineage spread and the expected TP53 mutation burden.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/epithelial-competition-determines-gene-therapy-potential-to-suppress-fanconi-anemia-oral-cancer-risk-research-article/369852/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/epithelial-competition-determines-gene-therapy-potential-to-suppress-fanconi-anemia-oral-cancer-risk-research-article/369852.png","ImageObject",300,407,{"name":42,"@type":43},"Franzy","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-07","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What problem does the study address about mucosal gene therapy in Fanconi Anemia?","Question",{"text":63,"@type":64},"It targets major knowledge gaps in how quickly gene-corrected cellular lineages could spread through oral epithelium and which delivery parameters are critical for efficient gene correction and cancer risk reduction.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does the model evaluate gene-corrected cell spread in the oral epithelium?",{"text":68,"@type":64},"It extends an agent-based model of the oral epithelium to include in situ delivery of gene correction to FA cells, comparing competitive dynamics between corrected and uncorrected lineages.",{"name":70,"@type":61,"acceptedAnswer":71},"What delivery strategies reduce the accumulation of pro-tumorigenic mutations?",{"text":72,"@type":64},"Delivering gene correction to many cells minimizes stochastic loss risk, while delivering to many distinct tissue locations maximizes the spread rate; under conditions such as elevated genome instability or TP53-dependent proliferative advantage, gene correction can substantially reduce TP53 mutation accumulation.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},369852,1790330932,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},2336478945519,"https://ap-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","OPEN ACCESS  \nCitation: Colegrove HL, Monnat Jr RJ, Feder AF (2025) Epithelial competition determines gene therapy potential to suppress Fanconi Anemia oral cancer risk. PLoS Comput Biol 21(9): e1012915. [https://doi.org/10.1371/journal](https://doi.org/10.1371/journal). pcbi.1012915  \nEditor: Michael J Plank, University of  \nCanterbury, NEW ZEALAND Received: February 25, 2025  \nAccepted: August 23, 2025  \nPublished: September 10, 2025  \nCopyright: © 2025 Colegrove et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.  \nData availability statement: The code to reproduce all analyses can be found at [https://github.com/federlab/](https://github.com/federlab/)[ ](https://github.com/federlab/)HomeostaticEpithelium_FAcorrection.  \nFunding: This work was supported by a Research Award from the Fanconi Cancer Foundation ([https://fanconi.org/](https://fanconi.org/)) to RJM and  \nRESEARCH ARTICLE  \nEpithelial competition determines gene therapy potential to suppress Fanconi Anemia oral cancer risk  \nHunter L. Colegrove1*, Raymond J. Monnat Jr.1,2,3, Alison F. Feder1,4*  \n1 Department of Genome Sciences, University of Washington, Seattle, Washington, United States of America, 2 Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, United States of America, 3 Department of Bioengineering, University of Washington, Seattle, Washington, United States of America, 4 Herbold Computational Biology Program, Fred Hutch Cancer Center, Seattle, Washington, United States of America  \n* [huntc10@uw.edu](huntc10@uw.edu) (HLC); [affeder@uw.edu](affeder@uw.edu) (AFF)  \nAbstract  \nFanconi Anemia (FA) is a heritable syndrome characterized by DNA damage repair deficits, frequent malformations and a significantly elevated risk of bone marrow failure, leukemia, and mucosal head and neck squamous cell carcinomas (HNSCC) . Hematopoietic stem cell gene therapy can prevent marrow failure and lower leukemia risk, but mucosal gene therapy to lower HNSCC risk remains untested. Major knowledge gaps include an incomplete understanding of how rapidly gene-corrected cellular lineages could spread through the oral epithelium, and which delivery parameters are critical for ensuring efficient gene correction. To answer these questions, we extended an agent-based model of the oral epithelium to include the delivery of gene correction in situ to FA cells and determine the competitive dynamics between cellular lineages with and without gene correction. We found that only gene-corrected lineages with substantial proliferative advantages (probability of resisting displacement out of the basal layer ≥ 0.1) could spread on clinically relevant timelines, and that these lineages were initially at high risk of loss in the generations following correction. Delivering gene correction to many cells minimizes the risk of loss, while delivery to many distinct locations within a tissue maximizes the rate of spread. To determine the impact of mucosal gene therapy in preventing the clonal expansion of pre-cancerous mutations, we compared the expected burden of TP53 mutations in simulated tissue sections with and without gene correction. We found that when FA cells have elevated genome instability or a TP53-dependent proliferative advantage, gene correction can substantially reduce the accumulation of pro-tumorigenic mutations. This model illustrates the power of computational frameworks to identify critical determinants of therapeutic success to enable experimental optimization and support novel and effective gene therapy applications.  \nPLOS Computational Biology | [https://doi.org/10.1371/journal.pcbi.1012915](https://doi.org/10.1371/journal.pcbi.1012915) September 10, 2025 1 / 22  \nby 1DP2CA280623 from the National Cancer Institute ([https://www.cancer.gov/]","cbCaibRDXi9mQpoO","https://ap.wps.com/l/cbCaibRDXi9mQpoO","pdf",2255069,22,"English","# Abstract\n## Introduction\n## Author summary","[{\"question\":\"What problem does the study address about mucosal gene therapy in Fanconi Anemia?\",\"answer\":\"It targets major knowledge gaps in how quickly gene-corrected cellular lineages could spread through oral epithelium and which delivery parameters are critical for efficient gene correction and cancer risk reduction.\"},{\"question\":\"How does the model evaluate gene-corrected cell spread in the oral epithelium?\",\"answer\":\"It extends an agent-based model of the oral epithelium to include in situ delivery of gene correction to FA cells, comparing competitive dynamics between corrected and uncorrected lineages.\"},{\"question\":\"What delivery strategies reduce the accumulation of pro-tumorigenic mutations?\",\"answer\":\"Delivering gene correction to many cells minimizes stochastic loss risk, while delivering to many distinct tissue locations maximizes the spread rate; under conditions such as elevated genome instability or TP53-dependent proliferative advantage, gene correction can substantially reduce TP53 mutation accumulation.\"}]","Epithelial competition determines gene therapy potential to suppress Fanconi Anemia oral cancer risk - Research article | PDF",1790184865,55,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c4e15da77df65b93072a250804f6fbb7.webp",983,1272,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b271de4b54d131cb3285d374c3f7b790.webp",982,1270,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6f28b28093a00abc7df927d96d1b8786.webp",981,1269,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0040916e4bddd95f6e82546904e738eb.webp",980,1268]